Securities Code: 300765 Securities Abbreviation: Shiyao Innovation Announcement No.: 2026-057
Shiyao Innovation Pharmaceutical Co., Ltd. Announcement on Carrying Out Foreign Exchange Hedging Business
The Company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.
Key Information Prompt:
- To hedge against foreign exchange market risks and reduce the impact of exchange rate fluctuations, the Company and its subsidiaries plan to conduct foreign exchange hedging business with an amount not exceeding USD 220 million or its equivalent in foreign currency, including but not limited to forward foreign exchange settlement and sales, foreign exchange swaps, foreign exchange options, and other foreign exchange derivative businesses.
- The Company held the third meeting of the Seventh Board of Directors on June 18, 2026, and reviewed and approved the "Proposal on Carrying Out Foreign Exchange Hedging Business." This matter needs to be submitted for approval by the Company's shareholders' meeting before it can be implemented.
- Risk Warning: The Company and its subsidiaries conduct foreign exchange hedging business in accordance with the principles of legality, prudence, safety, and effectiveness. However, there are still risks such as market fluctuation risk, internal control risk, and policy risk in the process of carrying out foreign exchange hedging business. Investors are reminded to pay attention to investment risks.
Shiyao Innovation Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the third meeting of the Seventh Board of Directors on June 18, 2026, and reviewed and approved the "Proposal on Carrying Out Foreign Exchange Hedging Business." The Company and its subsidiaries are approved to conduct foreign exchange hedging business with an amount not exceeding USD 220 million or its equivalent in foreign currency. This matter needs to be submitted for approval by the Company's shareholders' meeting before it can be implemented. The relevant matters are hereby announced as follows:
I. Overview of Investment Situation